The role of relaxin in endometrial cancer
Aparna A. Kamat(Baylor College of Medicine), Alexander I. Agoulnik(Florida International University), Farrah Kheradmand(Michael E. DeBakey VA Medical Center), Natalia V. Bogatcheva(Baylor College of Medicine), Shu Feng(University of Southern California), Anil K. Sood(The Ohio State University Wexner Medical Center), Donna Coffey(Cornell University), Irina U. Agoulnik(University of South Florida)
Cited by 65
Related Papers
Monitoring dopants by Raman scattering in an electrochemically top-gated graphene transistor
|Nature Nanotechnology|2008|3.6k
Rethinking ovarian cancer: recommendations for improving outcomes
|Nature reviews. Cancer|2011|1.5k
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k
Paraneoplastic Thrombocytosis in Ovarian Cancer
|New England Journal of Medicine|2012|822
Dicer, Drosha, and Outcomes in Patients with Ovarian Cancer
|New England Journal of Medicine|2008|719